[Liver surgery: what is feasible?].
BACKGROUND
Bilobar hepatic metastases, a small residual liver volume, de-novo and recurrent lesions, simultaneous pulmonary metastases and infiltration of vascular structures are often limiting factors in the surgical treatment of primary and secondary liver tumors. Nevertheless surgery is the "gold standard" with the chance of long-term survival, not possible to achieve with locally ablation and chemotherapy.


METHODS
The combination with neoadjuvant chemotherapy and radiofrequency ablation, extended liver resection after selective portal vein embolization, two-stage hepatectomy, resection and reconstruction of vascular structures in deep hypothermia and simultaneous resection of pulmonary metastases, increase the resectability even in patients with poor prognosis achieving 5-year-survival rates between 26-46 % in colorectal liver metastases, 40 % in primary liver tumors and a median survival of 42 months after resection of liver and lung metastases.


CONCLUSIONS
Interdisciplinary treatment and aggressive surgical resection seem to be justified, when performed safely as a curative option.
Ladurner
R
R
Abteilung für Allgemein-, Viszeral- und Transplantationschirurgie, Univ. Klinik Tübingen. ruth.ladurner@med.uni-tuebingen.de
Königsrainer
A
A
D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery*; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms; D003131:Combined Modality Therapy; D018450:Disease Progression; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D008175:Lung Neoplasms / Q000556:secondary / Q000601:surgery; D018579:Patient Selection; D010865:Pilot Projects; D011169:Portal Vein; D011379:Prognosis; D013997:Time Factors; D020246:Venous Thrombosis / Q000601:surgery / Q000628:therapy